CHERYL LEWIS: Open Payments
NPI 1942665591 · AUBURN, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 14 payments from 11 companies in 2025. Trend: 2023 $218 · 2024 $186 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| SPR Therapeutics, Inc | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Novo Nordisk Inc | 2 | $32 |
| Abbott Laboratories | 1 | $24 |
| Dexcom, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Amgen Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: RELISTOR, SPRINT PNS System, TRINTELLIX, FREESTYLE LIBRE 3, Dexcom G6 Transmitter, BREZTRI, JOURNAVX, Ozempic.
Industry payments across WA — which companies pay providers there.
